この画面を閉じる

文献元のページへ

ヒトES/iPS細胞用培地 StemFit® シリーズ

参考文献

  1. Inducible Transgene Expression in Human iPS Cells Using Versatile All-in-One piggyBac Transposons.
    Shin-Il Kim, et al. Methods Mol. Biol. 2016 1357:111-131.
  2. Establishment of In Vitro FUS-Associated Familial Amyotrophic Lateral Sclerosis Model Using Human Induced Pluripotent Stem Cells.
    Naoki Ichiyanagi, et al. Stem Cell Reports. 2016 Apr 12; 6(4): 496-510.
  3. Isolation of Human Induced Pluripotent Stem Cell-Derived Dopaminergic Progenitors by Cell Sorting for Successful Transplantation.
    Daisuke Doi, et al. Stem Cell Reports. 2014 Mar 11; 2(3): 337-350.
  4. Cardiomyocytes Derived from MHC-Homozygous Induced Pluripotent Stem Cells Exhibit Reduced Allogeneic Immunogenicity in MHC-Matched Non-human Primates.
    Takuji Kawamura, et al. Stem Cell Reports. 2016 Mar 8; 6(3): 312-320.
  5. Speciation of Intracellular Zn, Fe and Cu within both iPS Cells and Differentiated Cells Using HPLC Coupled to ICP-MS.
    Akihiro Arakawa, et al. J. Anal. Bioanal. Tech. 2016 7:295
  6. Genetic and pharmacological correction of aberrant dopamine synthesis using patient iPSCs with BH4 metabolism disorders.
    Ishikawa T, et al. Hum Mol Genet. (2016)25(23): 5188-5197
  7. Repurposing the Cord Blood Bank for Haplobanking of HLA-Homozygous iPSCs and Their Usefulness to Multiple Populations.
    Lee S, et al. Stem Clles. 2018. Jul 13
  8. CRISPR/Cas9-based Targeted Genome Editing for the Development of Monogenic Diseases Models with Human Pluripotent Stem Cells.
    Gupta N, et al. Curr Protoc Stem Cell Biol. 2018 May;45(1):e50.

この画面を閉じる